Sunday, July 18, 2010
As I mentioned these past two weeks, there was an FDA Advisory Committee (AdComm) meeting on July 13 and 14 that reviewed the safety of the diabetes drug Avandia (rosiglitazone). Transcripts of the sessions will someday be posted at the FDA website, at 2010 Meeting Materials, Endocrinologic and Metab...
My hat is off to you! Thank you for posting such informative blogs and keeping us posted on the Avandia issue, among others. It's always great to have a doctor in the house!! :)
Steve
http://thediabeticmindset.blogspot.com